COVID-19 pandemic containment in the Caribbean Region: A review of case-management and public health strategies

Umakanthan, Srikanth; Chauhan, Anuradha; Gupta, Madan M.; Sahu, Pradeep Kumar; Bukelo, Maryann M; Chattu, Vijay Kumar

doi:10.3934/publichealth.2021053

Cited by 12 publications

(13 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Low HL, mental stress, poor life satisfaction and an unhealthy diet are significantly associated with serious negative health outcomes 34 35. Based on the global health indices, the best-performing countries in combatting the ongoing COVID-19 pandemic have been those with smaller population, higher government funding allocation towards healthcare and those having robust public governance 36. The current study aims to investigate adherence to COVID-19 prevention measures and willingness to vaccinate against COVID-19, in relation to HL, perceived stress, life satisfaction and other participant’ sociodemographic and lifestyle characteristics, among the adult German population.…”

Section: Introductionmentioning

confidence: 99%

Retracted: Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study

Umakanthan

Lawrence²

2022

Postgraduate Medical Journal

Self Cite

View full text Add to dashboard Cite

Purpose of the studyAchieving high COVID-19 vaccination rates is a key public health challenge. The study aims to investigate factors determining COVID-19 vaccine hesitancy and adherence to prevention measures, in German adults.Study designThis cross-sectional study was conducted in Germany, from 21 February 2021 to 3 April 2021, during the strict lockdown period of the third COVID-19 wave. A total of 2029 adults (75.3% women and median age 38 years) participated in an online survey. Participants completed a questionnaire assessing sociodemographic and anthropometric characteristics, adherence to COVID-19 prevention measures and willingness to vaccinate. Health literacy (HL), perceived stress, life satisfaction and adherence to Mediterranean diet (MD) were also assessed. Multiple linear and logistic regression analysis were employed.ResultsThe median score of COVID-19 adherence to the prevention measures tool, was 23.08 (3.83) (range 1–35). A total of 57.5% of the participants were willing to vaccinate against COVID-19, 12.1% were unwilling and 30.4% were undecided. Linear regression analysis revealed that women, obese participants, those with a chronic disease and those willing to vaccinate, reported higher adherence to prevention measures. Older age, higher levels of HL, life satisfaction and adherence to MD were also positively associated with higher adherence. Logistic regression revealed that being a woman decreases the odds of having the willingness whereas, older age, higher education and adherence to measures, increase the odds of willingness to vaccinate.ConclusionThe results of the study could be used by practitioners, researchers and policy-makers working in the field of prevention and management of COVID-19.

show abstract

Section: Introductionmentioning

confidence: 99%

Retracted: Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study

Umakanthan

Lawrence²

2022

Postgraduate Medical Journal

Self Cite

View full text Add to dashboard Cite

show abstract

“…92,159 The generally favorable attitude towards COVID-19 vaccine acceptance might have contributed to generally high vaccine coverage observed in the Caribbean. 160 Fifth, several MENA region countries reported very low levels of COVID-19 vaccine acceptance (with six countries ranked among the top 10 countries with regard to COVID-19 vaccine hesitancy among the countries included in this review). This result was previously reported in an earlier systematic review that reported COVID-19 vaccine acceptance rates by the end of December 2020 and is further supported by the observations made in this review.…”

Section: Dovepressmentioning

confidence: 98%

A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review

Sallam¹,

Alsanafi²,

Sallam³

2022

JMDH

185

151

View full text Add to dashboard Cite

The delay or refusal of vaccination, which defines vaccine hesitancy, is a major challenge to successful control of COVID-19 epidemic. The huge number of publications addressing COVID-19 vaccine hesitancy necessitates periodic review to provide a concise summary of COVID-19 vaccine acceptance rates worldwide. In the current narrative review, data on COVID-19 vaccine acceptance rates were retrieved from surveys in 114 countries/ territories. In East and Southern Africa (n = 9), the highest COVID-19 vaccine acceptance rate was reported in Ethiopia (92%), while the lowest rate was reported in Zimbabwe (50%). In West/ Central Africa (n = 13), the highest rate was reported in Niger (93%), while the lowest rate was reported in Cameroon (15%). In Asia and the Pacific (n = 16), the highest rates were reported in Nepal and Vietnam (97%), while the lowest rate was reported in Hong Kong (42%). In Eastern Europe/Central Asia (n = 7), the highest rates were reported in Montenegro (69%) and Kazakhstan (64%), while the lowest rate was reported in Russia (30%). In Latin America and the Caribbean (n = 20), the highest rate was reported in Mexico (88%), while the lowest rate was reported in Haiti (43%). In the Middle East/North Africa (MENA, n = 22), the highest rate was reported in Tunisia (92%), while the lowest rate was reported in Iraq (13%). In Western/Central Europe and North America (n = 27), the highest rates were reported in Canada (91%) and Norway (89%), while the lowest rates were reported in Cyprus and Portugal (35%). COVID-19 vaccine acceptance rates ≥60% were seen in 72/114 countries/territories, compared to 42 countries/territories with rates between 13% and 59%. The phenomenon of COVID-19 vaccine hesitancy appeared more pronounced in the MENA, Europe and Central Asia, and Western/ Central Africa. More studies are recommended in Africa, Eastern Europe and Central Asia to address intentions of the general public to get COVID-19 vaccination.

show abstract

“…These are Pfizer which is an mRNA subtype vaccine, AstraZeneca is an adenovirus subtype 29 and Sinopharm is an inactivated whole virus subtype. 30 COVID-19 vaccination coverage varies significantly between countries reaching high percentages up to 86.2% in Sint Maarten 31 and 97.9% in United Arab Emirates and as low as 0.1% in Burundi. 32…”

Section: Discussionmentioning

confidence: 99%

Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study

Al‐Qerem¹,

Jarab²,

Hammad³

et al. 2022

PPA

View full text Add to dashboard Cite

Purpose COVID-19 vaccines are critical for containing the pandemic and preventing serious SARS-CoV-2 infections. In addition to the two main doses, a booster dose has been utilized to improve immunity. The aim of current study is to evaluate Iraqi adult population knowledge, attitudes, and practices towards COVID-19 booster dose. Subjects and Methods This online cross-sectional survey of adult Iraqis (n = 754) assessed the attitudes of people who have had both immunizations regarding a potential COVID-19 vaccine booster dosage and to identify potential factors that might impact these attitudes. Factors evaluated in the current study included previously received vaccine type in the first two doses, socioeconomic characteristics, health status, knowledge about COVID-19 and its vaccines and adherence to protective practices. Results Overall, 61.1% of participants expressed willingness to receive a COVID-19 booster dose, with a high median score of knowledge and practice toward COVID-19. Participants who did not perceive COVID-19 to be serious, p -value <0.001), participants who believed they would not be infected with COVID-19 in the next 6 months ( p -value <0.001), low knowledge score group ( p -value <0.001), lower education ( p -value <0.001), participants who received the COVID-19 vaccine because of imposed laws ( p -value <0.001), participants who received AstraZeneca vaccine ( p -value <0.001), younger participants ( p -value=0.003), low level of practice ( p -value <0.001), participants who did not know someone who had died due to COVID-19 ( p -value=0.01), low risk of developing serious side effects if infected with COVID-19 and participants in the low side effects score were significantly less frequently willing to receive a booster COVID-19 dose ( p -value <0.001). The main reasons for booster dose hesitancy/refusal were the perceived lack of need for a booster shot, the uselessness of a booster shot and the conspiracy theory of boosting corporate profits through booster shots. Conclusion There is high hesitancy towards COVID-19 booster dose acceptance among the Iraqi population. The study identified several factors associated with vaccine hesitancy including low socioeconomic status and low knowledge about COVID-19 and its vaccines.

show abstract

COVID-19 pandemic containment in the Caribbean Region: A review of case-management and public health strategies

Cited by 12 publications

References 58 publications

Retracted: Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study

Retracted: Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study

A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review

Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study

Contact Info

Product

Resources

About